2007-2023年以色列产OXA-48样碳青霉烯酶大肠埃希菌出现与传播的基于人群研究
该研究基于以色列国家监测系统的数据和分离株,开展基于人群的研究,调查产OXA-48样碳青霉烯酶大肠埃希菌(OXA-EC)的出现与传播。2007-2023年共发生3510例OXA-ECincident病例;2016-2023年年病例数从41例升至1524例,非医院获得性病例占比从39%升至57%。63株测序分离株属20个序列型(ST)和3种blaOXA等位基因,71%为染色体编码、29%为质粒编码,医院与非医院获得性分离株属于相同ST和等位基因,多数暴发涉及多个ST且仅部分可用质粒传播解释。
要点
- 2016-2023年OXA-EC年病例数从41例升至1524例。
- 非医院获得性病例占比从39%升至57%。
- 多数暴发涉及多个ST,仅部分可用质粒传播解释。
核心结论
- 应对OXA-EC的措施可能需要重新考虑。
研究设计与样本
- 基于人群的研究,使用以色列国家监测系统的数据和分离株,研究2007-2023年OXA-EC的出现与传播。
主要发现
- 2007-2023年共发生3510例OXA-ECincident病例。
- 2016-2023年,年病例数从41例升至1524例,非医院获得性病例占比从39%升至57%。
- 63株测序分离株属于20个序列型(ST)和3种blaOXA等位基因(blaOXA-244、blaOXA-48和blaOXA-181)。
- 71%的测序分离株为染色体编码,29%为质粒编码。
- 医院获得性与非医院获得性分离株属于相同的ST和等位基因,多数暴发涉及多个ST且仅部分可用质粒传播解释。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Escherichia coli producing OXA-48-like carbapenemases (OXA-EC) is considered a high-risk pathogen spread primarily in the community in low- and middle-income countries and nosocomially in high-income countries. We investigated the emergence and spread of OXA-EC in Israel, a high-income country with strong carbapenemase-directed infection control in healthcare institutions, by conducting a population-based study using data and isolates from the national surveillance system. A total of 3,510 incident cases of OXA-EC occurred during 2007-2023. During 2016-2023, annual cases rose from 41 to 1,524 and nonnosocomial cases rose from 39% to 57%. Sixty-three sequenced isolates belonged to 20 sequence types (STs) and had 3 blaOXA alleles (blaOXA-244, blaOXA-48, and blaOXA-181); 71% were chromosomally encoded, and 29% were plasmid-encoded. Nosocomially and non-nosocomially acquired isolates belonged to the same STs and alleles. Most outbreaks involved multiple STs and could only partially be explained by plasmid dissemination. Measures for confronting OXA-EC might need reconsideration.
引用
- Temkin E, Bechor M, Lurie-Weinberger MN, et al. Population-Based Study of Emergence and Spread of Escherichia coli Producing OXA-48-Like Carbapenemases, Israel, 2007-2023. Emerg Infect Dis. 2025. PMID: 39714269. doi:10.3201/eid3101.240722
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。